Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO

Source :: Plus Company Updates. May 31, 2024
Publication Year :: 2024
Abstract: SAN DIEGO: Illumina, Inc. has issued the following news release: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of its latest research [...]

Subjects :: Illumina Inc.
Standards
Genetic testing
Genetic research
DNA sequencing
Biotechnology industries -- Standards
Nucleotide sequencing
Biotechnology industry -- Standards
Genetic screening

Tools